19:48 IST
BSE
Earnings Call
Innovassynth Technologies (India) Investor Presentation: Key Takeaways
Innovassynth reported sharp Q1FY27 recovery with Revenue of ₹55.99 Cr and 27% EBITDA margin. Strategy focuses on CRDMO expansion in Life Sciences and Specialty Chemicals for US/EU markets.